News2 weeks ago
Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program
— FDA has provided clearance to the company to continue dosing patients who have already undergone lymphodepletion — REDWOOD CITY, Calif., June 19, 2023 /PRNewswire/ —...
